2025-04-012026-03-312026-03-31false07576566SAFA Diagnostics Limited2026-06-0186900falseiso4217:GBPxbrli:pure075765662025-03-31075765662026-03-31075765662025-04-012026-03-31075765662024-03-31075765662025-03-31075765662024-04-012025-03-3107576566bus:SmallEntities2025-04-012026-03-3107576566bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3107576566bus:FullAccounts2025-04-012026-03-3107576566bus:PrivateLimitedCompanyLtd2025-04-012026-03-3107576566core:WithinOneYear2026-03-3107576566core:AfterOneYear2026-03-3107576566core:WithinOneYear2025-03-3107576566core:AfterOneYear2025-03-3107576566core:ShareCapital2026-03-3107576566core:SharePremium2026-03-3107576566core:RevaluationReserve2026-03-3107576566core:OtherReservesSubtotal2026-03-3107576566core:RetainedEarningsAccumulatedLosses2026-03-3107576566core:ShareCapital2025-03-3107576566core:SharePremium2025-03-3107576566core:RevaluationReserve2025-03-3107576566core:OtherReservesSubtotal2025-03-3107576566core:RetainedEarningsAccumulatedLosses2025-03-3107576566core:LandBuildings2026-03-3107576566core:PlantMachinery2026-03-3107576566core:Vehicles2026-03-3107576566core:FurnitureFittings2026-03-3107576566core:OfficeEquipment2026-03-3107576566core:NetGoodwill2026-03-3107576566core:IntangibleAssetsOtherThanGoodwill2026-03-3107576566core:ListedExchangeTraded2026-03-3107576566core:UnlistedNon-exchangeTraded2026-03-3107576566core:LandBuildings2025-03-3107576566core:PlantMachinery2025-03-3107576566core:Vehicles2025-03-3107576566core:FurnitureFittings2025-03-3107576566core:OfficeEquipment2025-03-3107576566core:NetGoodwill2025-03-3107576566core:IntangibleAssetsOtherThanGoodwill2025-03-3107576566core:ListedExchangeTraded2025-03-3107576566core:UnlistedNon-exchangeTraded2025-03-3107576566core:LandBuildings2025-04-012026-03-3107576566core:PlantMachinery2025-04-012026-03-3107576566core:Vehicles2025-04-012026-03-3107576566core:FurnitureFittings2025-04-012026-03-3107576566core:OfficeEquipment2025-04-012026-03-3107576566core:NetGoodwill2025-04-012026-03-3107576566core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3107576566core:ListedExchangeTraded2025-04-012026-03-3107576566core:UnlistedNon-exchangeTraded2025-04-012026-03-3107576566core:MoreThanFiveYears2025-04-012026-03-3107576566core:Non-currentFinancialInstruments2026-03-3107576566core:Non-currentFinancialInstruments2025-03-3107576566dpl:CostSales2025-04-012026-03-3107576566dpl:DistributionCosts2025-04-012026-03-3107576566core:LandBuildings2025-04-012026-03-3107576566core:PlantMachinery2025-04-012026-03-3107576566core:Vehicles2025-04-012026-03-3107576566core:FurnitureFittings2025-04-012026-03-3107576566core:OfficeEquipment2025-04-012026-03-3107576566dpl:AdministrativeExpenses2025-04-012026-03-3107576566core:NetGoodwill2025-04-012026-03-3107576566core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3107576566dpl:GroupUndertakings2025-04-012026-03-3107576566dpl:ParticipatingInterests2025-04-012026-03-3107576566dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3107576566core:ListedExchangeTraded2025-04-012026-03-3107576566dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3107576566core:UnlistedNon-exchangeTraded2025-04-012026-03-3107576566dpl:CostSales2024-04-012025-03-3107576566dpl:DistributionCosts2024-04-012025-03-3107576566core:LandBuildings2024-04-012025-03-3107576566core:PlantMachinery2024-04-012025-03-3107576566core:Vehicles2024-04-012025-03-3107576566core:FurnitureFittings2024-04-012025-03-3107576566core:OfficeEquipment2024-04-012025-03-3107576566dpl:AdministrativeExpenses2024-04-012025-03-3107576566core:NetGoodwill2024-04-012025-03-3107576566core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107576566dpl:GroupUndertakings2024-04-012025-03-3107576566dpl:ParticipatingInterests2024-04-012025-03-3107576566dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107576566core:ListedExchangeTraded2024-04-012025-03-3107576566dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107576566core:UnlistedNon-exchangeTraded2024-04-012025-03-3107576566core:NetGoodwill2026-03-3107576566core:IntangibleAssetsOtherThanGoodwill2026-03-3107576566core:LandBuildings2026-03-3107576566core:PlantMachinery2026-03-3107576566core:Vehicles2026-03-3107576566core:FurnitureFittings2026-03-3107576566core:OfficeEquipment2026-03-3107576566core:AfterOneYear2026-03-3107576566core:WithinOneYear2026-03-3107576566core:ListedExchangeTraded2026-03-3107576566core:UnlistedNon-exchangeTraded2026-03-3107576566core:ShareCapital2026-03-3107576566core:SharePremium2026-03-3107576566core:RevaluationReserve2026-03-3107576566core:OtherReservesSubtotal2026-03-3107576566core:RetainedEarningsAccumulatedLosses2026-03-3107576566core:NetGoodwill2025-03-3107576566core:IntangibleAssetsOtherThanGoodwill2025-03-3107576566core:LandBuildings2025-03-3107576566core:PlantMachinery2025-03-3107576566core:Vehicles2025-03-3107576566core:FurnitureFittings2025-03-3107576566core:OfficeEquipment2025-03-3107576566core:AfterOneYear2025-03-3107576566core:WithinOneYear2025-03-3107576566core:ListedExchangeTraded2025-03-3107576566core:UnlistedNon-exchangeTraded2025-03-3107576566core:ShareCapital2025-03-3107576566core:SharePremium2025-03-3107576566core:RevaluationReserve2025-03-3107576566core:OtherReservesSubtotal2025-03-3107576566core:RetainedEarningsAccumulatedLosses2025-03-3107576566core:NetGoodwill2024-03-3107576566core:IntangibleAssetsOtherThanGoodwill2024-03-3107576566core:LandBuildings2024-03-3107576566core:PlantMachinery2024-03-3107576566core:Vehicles2024-03-3107576566core:FurnitureFittings2024-03-3107576566core:OfficeEquipment2024-03-3107576566core:AfterOneYear2024-03-3107576566core:WithinOneYear2024-03-3107576566core:ListedExchangeTraded2024-03-3107576566core:UnlistedNon-exchangeTraded2024-03-3107576566core:ShareCapital2024-03-3107576566core:SharePremium2024-03-3107576566core:RevaluationReserve2024-03-3107576566core:OtherReservesSubtotal2024-03-3107576566core:RetainedEarningsAccumulatedLosses2024-03-3107576566core:AfterOneYear2025-04-012026-03-3107576566core:WithinOneYear2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3107576566core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3107576566core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3107576566core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107576566core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107576566core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107576566bus:Director12025-04-012026-03-3107576566bus:Director22025-04-012026-03-31

SAFA Diagnostics Limited

Registered Number
07576566
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

SAFA Diagnostics Limited
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

Sandra Bode-Fallahi
Dr Farshid Fallahi

Company Secretary

Sandra Bode-Fallahi

Registered Address

1 Holme Farm Court
Cumwhinton
Carlisle
CA4 8DS

Registered Number

07576566 (England and Wales)
SAFA Diagnostics Limited
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets31,5661,842
1,5661,842
Current assets
Cash at bank and on hand30,31924,319
30,31924,319
Creditors amounts falling due within one year5(29,622)(26,122)
Net current assets (liabilities)697(1,803)
Total assets less current liabilities2,26339
Net assets2,26339
Capital and reserves
Called up share capital101101
Profit and loss account2,162(62)
Shareholders' funds2,26339
The financial statements were approved and authorised for issue by the Board of Directors on 1 June 2026, and are signed on its behalf by:
Dr Farshid Fallahi
Director
Sandra Bode-Fallahi
Director

Registered Company No. 07576566
SAFA Diagnostics Limited
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Judgements and key sources of estimation uncertainty
Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. There are no key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery15
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 April 259,0839,083
At 31 March 269,0839,083
Depreciation and impairment
At 01 April 257,2417,241
Charge for year276276
At 31 March 267,5177,517
Net book value
At 31 March 261,5661,566
At 31 March 251,8421,842
4.Impairment of tangible fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
5.Creditors: amounts due within one year

2026

2025

££
Taxation and social security5,4694,334
Other creditors23,37321,008
Accrued liabilities and deferred income780780
Total29,62226,122
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.